This Week in Cardiology

Rivaroxaban and GI bleeding, CT angiography for chest pain, long-term results of the COURAGE trial, bioprosthetic valve thrombosis, and EMR are reviewed in this week's podcast.

Watchman CMS proposal, NICE proposal on evolocumab in the UK, cryptogenic stroke, disclosing genetic risk of future CHD, and coffee intake are the topics for this week's podcast from Dr John Mandrola.

Dr John Mandrola reviews multiple studies from the American Heart Association 2015 Scientific Sessions in this week's podcast.

The modified Valsalva technique for PSVT termination, the DoJ settlement for ICDs, combat stress and future heart disease, Califf for FDA boss, and an AHA preview are topics reviewed by Dr John Mandrola in this week's podcast.

Dabigatran in women, advance practice practitioners in cardiology, burst exercise for type 2 diabetes, cannabis and ischemic stroke, and Science of the Art of Medicine are reviewed by Dr Mandrola.

Treating patients with severe asymptomatic aortic stenosis, dabigatran reversal, valve-in-valve TAVR, and an oral potassium binder are the topics for this week's podcast from Dr John Mandrola

Radial vs femoral access in PCI, thrombus aspiration, beta-blocker use in noncardiac surgery, CETP failure, PCSK9 costs, and Dr. Muhkerjee's three laws of medicine are reviewed in this week's podcast.

Possible aortic-valve thrombosis, coronary calcium, amiodarone, remote ischemic preconditioning, cancer and the heart are topics for this week's podcast with John Mandrola

Knowledge gaps in HF caregivers, LCZ696, cerebral lesions and HF, gender differences in post-MI care, new SVT guidelines, and precision medicine are reviewed by Dr John Mandrola.

The not-so-high risk of carotid artery occlusion, empagliflozin for type 2 DM, text messages for secondary prevention of heart disease, coffee and AF, ICD-10, and medical errors are the topics discussed by Dr John Mandrola in this week's podcast.